Lisa Jones1, Geoff Bates2, Ellie McCoy2, Caryl Beynon2, James McVeigh2, Mark A Bellis3. 1. 1 Centre for Public Health, Faculty of Education, Health and Community, Liverpool John Moores University, 15-21 Webster Street, Liverpool L3 2ET, UK l.jones1@ljmu.ac.uk. 2. 1 Centre for Public Health, Faculty of Education, Health and Community, Liverpool John Moores University, 15-21 Webster Street, Liverpool L3 2ET, UK. 3. 2 Public Health Wales, Haydn Ellis Building, Maindy Road, Cardiff CF24 4HQ, UK.
Abstract
BACKGROUND: People who inject drugs are at the greatest risk of acquiring hepatitis C virus infection in many high-income countries, including those in Europe. Our review examined the effectiveness of interventions aimed at increasing hepatitis C virus testing uptake. METHODS: We undertook a systematic review of controlled studies. Searches of 13 databases were supplemented with citation searching, and manual searches of reference lists and websites. Studies of interventions that aimed to increase testing uptake among high-risk groups were included. Testing uptake was our primary outcome measure of interest and secondary outcomes were engagement in follow-up services and treatment. A narrative synthesis was undertaken. RESULTS: Eight controlled studies were included. Three studies examined interventions in primary care; one examined dried blood spot testing as an alternative method of testing, and two examined outreach provision. Two further studies examined interventions to improve hepatitis C management. Targeted case finding in primary care, support and training for primary care practitioners, offering alternative testing and provision of outreach testing all increased uptake of testing; however, intervention effects were variable. CONCLUSIONS: Evidence from the available studies suggests that increases in testing uptake can be achieved. Careful attention needs to be paid to the resource implications associated with implementation of interventions in primary care settings and also of the potential for interventions to improve outcomes once a positive diagnosis has been made. Further research on the cost-effectiveness of the intervention approaches examined in this review is required.
BACKGROUND:People who inject drugs are at the greatest risk of acquiring hepatitis C virus infection in many high-income countries, including those in Europe. Our review examined the effectiveness of interventions aimed at increasing hepatitis C virus testing uptake. METHODS: We undertook a systematic review of controlled studies. Searches of 13 databases were supplemented with citation searching, and manual searches of reference lists and websites. Studies of interventions that aimed to increase testing uptake among high-risk groups were included. Testing uptake was our primary outcome measure of interest and secondary outcomes were engagement in follow-up services and treatment. A narrative synthesis was undertaken. RESULTS: Eight controlled studies were included. Three studies examined interventions in primary care; one examined dried blood spot testing as an alternative method of testing, and two examined outreach provision. Two further studies examined interventions to improve hepatitis C management. Targeted case finding in primary care, support and training for primary care practitioners, offering alternative testing and provision of outreach testing all increased uptake of testing; however, intervention effects were variable. CONCLUSIONS: Evidence from the available studies suggests that increases in testing uptake can be achieved. Careful attention needs to be paid to the resource implications associated with implementation of interventions in primary care settings and also of the potential for interventions to improve outcomes once a positive diagnosis has been made. Further research on the cost-effectiveness of the intervention approaches examined in this review is required.
Authors: Joanne E Brady; Danielle K Liffmann; Anthony Yartel; Natalie Kil; Alex D Federman; Joseph Kannry; Cynthia Jordan; Omar I Massoud; David R Nerenz; Kimberly A Brown; Bryce D Smith; Claudia Vellozzi; David B Rein Journal: Hepatology Date: 2016-11-25 Impact factor: 17.425
Authors: David Ortiz-Paredes; Afia Amoako; Taline Ekmekjian; Kim Engler; Bertrand Lebouché; Marina B Klein Journal: Front Public Health Date: 2022-06-24
Authors: Bao Ngoc Vu; Kim Do Tuan; An Khanh Tran; Long Khanh Tran; Kimberly Green; Khoa Trong Nguyen; Phuong Duc Cao Journal: Clin Liver Dis (Hoboken) Date: 2022-04-29
Authors: Esther Jane Aspinall; Joseph Samuel Doyle; Stephen Corson; Margaret Elena Hellard; David Hunt; David Goldberg; Tim Nguyen; Yngve Falck-Ytter; Rebecca Lynn Morgan; Bryce Smith; Mark Stoove; Stefan Zbyszko Wiktor; Sharon Hutchinson Journal: Eur J Epidemiol Date: 2014-11-11 Impact factor: 8.082
Authors: Kimberly Page; Michelle Yu; Jennifer Cohen; Jennifer Evans; Martha Shumway; Elise D Riley Journal: BMC Public Health Date: 2017-02-07 Impact factor: 3.295
Authors: Sonia Vázquez-Morón; Beatriz Ardizone Jiménez; María A Jiménez-Sousa; José M Bellón; Pablo Ryan; Salvador Resino Journal: Sci Rep Date: 2019-05-13 Impact factor: 4.379
Authors: Claude Bernard Uwizeye; Hervé Tchala Vignon Zomahoun; André Bussières; Aliki Thomas; Dahlia Kairy; José Massougbodji; Nathalie Rheault; Sébastien Tchoubi; Leonel Philibert; Serigne Abib Gaye; Lobna Khadraoui; Ali Ben Charif; Ella Diendéré; Léa Langlois; Michèle Dugas; France Légaré Journal: Interact J Med Res Date: 2022-07-11